Ann Rehabil Med.
2013 Jun;37(3):420-425. 10.5535/arm.2013.37.3.420.
A Case of the Cauda Equina Syndrome Associated With the Intrathecal Chemotherapy in a Patient With Primary Central Nervous System Lymphoma
- Affiliations
-
- 1Department of Rehabilitation Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, Korea. leej@kuh.ac.kr
- KMID: 2219540
- DOI: http://doi.org/10.5535/arm.2013.37.3.420
Abstract
- The intrathecal chemotherapy with methotrexate and cytarabine arabinoside is used for the treatment and prophylaxis of the primary central nervous system lymphoma. The therapy may induce neurotoxicity including the cauda equina syndrome. We report a case of a 58-year-old man with the diffuse large B-cell lymphoma, who developed the cauda equina syndrome after the administration of intrathecal methotrexate and cytarabine arabinoside, as diagnosed by the electrodiagnostic, urodynamic, and radiologic approaches.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Drop Metastasis of Adrenocorticotropic Hormone-Producing Pituitary Carcinoma to the Cauda Equina
- Two Cases of Treatment with Intrathecal Rituximab for Primary Central Nervous System Lymphoma
- Cauda Equina Syndrome Following Intrathecal Hypertonic Saline Administration
- A Case of Primary Lymphoma Presenting as Cauda Equina Syndrome
- MR Imaging Characteristics of Primary T-Cell Lymphoma of the Cauda Equina: A Case Report and Literature Review
